The medical technology industry is highly competitive and continues to evolve, with success measured by the development of innovative products and the value brought to stakeholders. The firm is committed to developing new technologies and providing innovative patient care, which underscores the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. In 2019, the firm invested 17.3% of net sales in research and development, reflecting a focus on enhancing IT capabilities to support business needs and operational efficiency. The acquisition of Casmed, a medical technology company dedicated to noninvasive monitoring, illustrates the strategic resource allocation towards enhancing IT functionalities and capabilities. The firm’s IT capabilities represent the application of both physical and intangible IT resources, such as technology, knowledge, practices, and management skills, to further organizational goals. The increase in net sales of transcatheter aortic valve replacement products was driven by strong therapy adoption and regulatory approvals, demonstrating the impact of effective IT deployment on market agility and competitive advantage. The firm is dedicated to generating robust clinical, economic, and quality of life evidence, which is increasingly expected by patients and clinicians, indicating a strategic alignment of IT capabilities with business innovation. The operational flexibility achieved through the hemosphere advanced monitoring platform exemplifies the integration of IT systems in enhancing customer relationships and improving firm performance. The firm’s commitment to defending intellectual property and investing in technology resources is essential for maintaining a competitive position in the market. Additionally, the increase in selling, general, and administrative expenses was primarily due to higher personnel-related costs, which are critical for supporting IT governance and management capability. The firm’s focus on process optimization and the integration of technology capabilities into its operations is vital for achieving performance gains and enhancing organizational effectiveness. The strategic decisions regarding the transcatheter aortic valve portfolio reflect the importance of IT capability in resource mobilization and investment choices, which are essential for navigating the challenges of a dynamic healthcare environment. The firm’s ability to provide data and information with appropriate levels of accuracy, timeliness, and reliability is crucial for meeting changing business needs and directions. Overall, the evolving IT capabilities are integral to transforming the firm into a competitive force, enabling it to respond effectively to market dynamics and consumer demands while fostering innovation and operational excellence.